< Back to previous page
Researcher
Thomas Voets
- Disciplines (Flanders Institute for Biotechnology):Analysis of next-generation sequence data, Cell death, Behavioural neuroscience
- Disciplines (KU Leuven):Physiology
- See also: Thomas Voets (Flanders Institute for Biotechnology)
Affiliations
- Laboratory of Ion Channel Research (VIB-KU Leuven) (Division)
Responsible
From1 Jan 2012 → Today - Voets Lab (Research group)
Responsible
From1 Jul 2017 → Today - Laboratory of Ion Channel Research (VIB-KU Leuven) (Division)
Member
From1 Oct 2007 → Today - Faculty of Medicine (Faculty)
Member
From1 Oct 2002 → 30 Sep 2003
Projects
41 - 50 of 56
- Biophysical characterization and validation of TRPM3 as nociceptorFrom1 Sep 2012 → 30 Sep 2017Funding: FWO fellowships
- Integration of cellular signaling pathways in health and disease.From1 Apr 2012 → 31 Dec 2017Funding: IUAP-VII
- Exploring the role of TRP ion channels in the molecular mechanisms of exocytosis.From1 Jan 2012 → 31 Dec 2017Funding: FWO research project (including WEAVE projects)
- Transient receptor potential cation channels as molecular sensors of bacterial endotoxins.From1 Jan 2012 → 31 Dec 2017Funding: FWO research project (including WEAVE projects)
- The role of TRP channels in noxious heat sensingFrom1 Aug 2011 → 6 Feb 2017Funding: Own budget, for example: patrimony, inscription fees, gifts
- Mechanisms of modulation of Transient Receptor Potential cation channels by bacterial endotoxinsFrom1 Mar 2011 → 31 Dec 2015Funding: IWT personal funding - strategic basic research grants
- Characterisation of TRPM3, a novel heat-sensitive ion channel in nociceptors.From1 Jan 2011 → 31 Dec 2014Funding: FWO research project (including WEAVE projects)
- TRPLe: TRP Research Platform Leuven.From1 Nov 2010 → 31 Oct 2017Funding: BOF - Concerted Research Project from 1994
- The role of thermoTRPs in the normal and the overactive bladder.From1 Oct 2010 → 10 Dec 2015Funding: FWO fellowships
- An imaging platform for recording cellular activity at high temporal resolution.From22 Jul 2010 → 21 Jan 2017Funding: Hercules - Small and Medium size research infrastructure
Publications
1 - 10 of 231
- pH-dependent modulation of TRPV1 by modality-selective antagonists(2023)
Authors: Thomas Voets
Pages: 2750 - 2761 - β-Lactam TRPM8 Antagonists Derived from Phe-Phenylalaninol Conjugates: Structure-Activity Relationships and Antiallodynic Activity(2023)
Authors: Thomas Voets
- TRPM3 as a novel target to alleviate acute oxaliplatin-induced peripheral neuropathic pain(2023)
Authors: Davide Aloi, Thomas Voets, Joris Vriens
Pages: 2060 - 2069 - Primidone improves symptoms in TRPM3-linked developmental and epileptic encephalopathy with spike-and-wave activation in sleep(2023)
Authors: Evelien Van Hoeymissen, Thomas Voets, Joris Vriens
Pages: e61 - e68 - Protease secretions by the invading blastocyst induce calcium oscillations in endometrial epithelial cells via the protease-activated receptor 2(2023)
Authors: Katrien De Clercq, Karen Peeraer, Hugo Vankelecom, Thomas Voets, Joris Vriens
- Clotrimazole-Based Modulators of the TRPM3 Ion Channel Reveal Narrow Structure-Activity Relationship(2023)
Authors: Thomas Voets, Joris Vriens, Steven Verhelst
Pages: 456 - 464 - Gain- of- function variants in the ion channel gene TRPM3 underlie a spectrum of neurodevelopmental disorders(2023)
Authors: Evelien Van Hoeymissen, Katrien De Clercq, Thomas Voets, Joris Vriens
- Inhibition of TRPM8 by the urinary tract analgesic drug phenazopyridine.(2023)
Authors: Jan Daniluk, Annelies Janssens, Marie Mulier, Wouter Everaerts, Thomas Voets
- TRPM3 as novel target to alleviate acute oxaliplatin-induced peripheral neuropathy.(2022)
Authors: Davide Aloi, Joris Vriens, Thomas Voets
Number of pages: 10 - TRPM4 inhibition by meclofenamate suppresses Ca2+-dependent triggered arrhythmias(2022)
Authors: Andy Pironet, Sara Kerselaers, Joren Verelst, Wouter Oosterlinck, Bernd Nilius, Thomas Voets, Rudi Vennekens
Pages: 4195 - +
Patents
1 - 4 of 4
- Aryl derivatives for treating trpm3 mediated disorders (Inventor)
- Heterocycle derivatives for treating trpm3 mediated disorders (Inventor)
- Screening method for analgesic agents (Inventor)
- Treatment of pain (Inventor)